| View |
|
DR-XY48922
|
Benzydamine Hydrochloride + Digluconate
|
Symptoblo
|
1.5mg/1.2 mg per mL
|
Oromucosal Spray
|
-
|
Humanis Sağlık Anonim Şirketi
|
Turkey
|
Initial [OTC]
|
17 November 2023
|
17 November 2028
|
| View |
|
DRHR-2314
|
Ethyl Alcohol
|
Biogenic
|
70% Solution
|
Solution For External Use
|
-
|
Cosmetique Asia Corporation
|
Philippines
|
Initial [OTC]
|
17 November 2023
|
17 November 2028
|
| View |
|
DRP-14656
|
Dexketoprofen (as trometamol)
|
Keprofyn
|
25 mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
17 November 2023
|
17 November 2028
|
| View |
|
DRP-14590
|
Paracetamol + Orphenadrine Citrate
|
Orphemol
|
650 mg/35 mg
|
Film-Coated Tablet
|
-
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
21 November 2023
|
21 November 2028
|
| View |
|
DRP-14655
|
Cilostazol
|
Cirozit
|
100 mg
|
Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
17 November 2023
|
17 November 2028
|
| View |
|
DRP-14658
|
Aripiprazole
|
Abizol Easytab
|
10 mg
|
Orodispersible Tablet
|
-
|
Nobel İlaç Sanayii ve Ticaret A.Ş
|
Turkey
|
Initial
|
17 November 2023
|
17 November 2028
|
| View |
|
DR-XY48929
|
Entrectinib
|
Rozlytrek
|
100 mg
|
Capsule
|
-
|
Mayne Pharma Inc.
|
USA
|
Monitored Release (Re-application)
|
23 November 2023
|
23 November 2028
|
| View |
|
DR-XY48930
|
Entrectinib nib
|
Rozlytrek
|
200 mg
|
Capsule
|
-
|
Mayne Pharma Inc.
|
USA
|
Monitored Release (Re-application)
|
23 November 2023
|
22 November 2028
|
| View |
|
DRP-14657
|
Aciclovir
|
none
|
200 mg
|
Tablet
|
-
|
Medico Remedies Limited
|
India
|
Initial
|
17 November 2023
|
17 November 2028
|
| View |
|
DRP-14682
|
Sorafenib (as tosylate)
|
Onconib
|
200 mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
22 November 2023
|
22 November 2028
|
| View |
|
DRP-14688
|
Ketamine (as hydrochloride)
|
Ketolex
|
50 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Farbe Firma Pvt. Ltd.
|
India
|
Initial
|
23 November 2023
|
23 November 2028
|
| View |
|
DRP-14681
|
Cefixime (as trihydrate)
|
Cefiglob-400
|
400 mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
22 November 2023
|
22 November 2028
|
| View |
|
DRP-14665
|
Mupirocin
|
Mupistar
|
20 mg/g (2% w/w)
|
Topical Ointment.
|
-
|
S Kant Healthcare Ltd.
|
India
|
Initial
|
21 November 2023
|
21 November 2028
|
| View |
|
DRP-14666
|
Paclitaxel
|
Pacliget
|
6 mg/mL (100 mg/16.7 mL)
|
Solution for IV Infusion
|
Antineoplastic Agent (Taxane)
|
Venus Remedies Limited.
|
India
|
Initial (Correction)
|
30 January 2024
|
21 November 2028
|
| View |
|
DRP-14667
|
Zoledronic Acid (as monohydrate)
|
Zologet
|
4 mg
|
Lyophilized Powder for IV Infusion
|
-
|
Venus Remedies Limited
|
India
|
Initial
|
21 November 2023
|
21 November 2028
|
| View |
|
DRP-14683
|
Meropenem
|
Merobest 500
|
500 mg
|
Powder for Injection (I.V.)
|
-
|
Mason Pharma
|
India
|
Initial (Re-application)
|
22 November 2023
|
22 November 2028
|
| View |
|
BRP-100-09
|
Epoetin Alfa
|
Eprotex
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
08 December 2023
|
14 December 2026
|
| View |
|
DRP-10017-01
|
Cloxacillin (as sodium)
|
Clozac-250
|
250 mg per 5 mL
|
Powder for Solution
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
20 October 2024
|
07 January 2030
|
| View |
|
DRP-10087-02
|
Betamethasone (as dipropionate)
|
Eczigone
|
500 mcg / g (0.05 % w/w)
|
Topical Cream
|
Corticosteroid
|
S Kant Healthcare Limited
|
India
|
CLIDP Conversion
|
08 December 2023
|
30 October 2025
|
| View |
|
DRP-10246-07
|
Ceftriaxone (as sodium)
|
Retaxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
01 October 2026
|